TCR2 Therapeutics' Series A Round

TCR2 Therapeutics raised a round of funding on December 07, 2016.

TCR2 Therapeutics, founded by MPM Capital, is a discovery stage pharmaceutical company focused on engineering T cells for cancer therapy. The company's vast expertise in T cell engagement and a deep u…

Articles about TCR2 Therapeutics' Series A Round: